List of Review Contributors |
|
xi | |
Preface |
|
xiii | |
CHAPTER 1 DIAGNOSIS AND CLASSIFICATION OF PHOBIAS |
|
1 | (60) |
|
Diagnosis and Classification of Phobias: A Review |
|
|
1 | (32) |
|
Isaac Marks and David Mataix-Cols |
|
|
|
|
|
1.1 Two Procrustean or One King-Size Bed for Comorbid Agoraphobia and Panic? |
|
|
33 | (3) |
|
|
|
1.2 Politics and Pathophysiology in the Classification of Phobias |
|
|
36 | (2) |
|
|
|
1.3 A Critical Evaluation of the Classification of Phobias |
|
|
38 | (2) |
|
|
|
1.4 The Role of Spontaneous, Unexpected Panic Attacks in the Diagnosis and Classification of Phobic Disorders |
|
|
40 | (3) |
|
Giulio Perugi and Cristina Toni |
|
|
|
1.5 Anxiety and Phobia: Issues in Classification |
|
|
43 | (3) |
|
|
|
1.6 Nosology of the Phobias: Clues from the Genome |
|
|
46 | (1) |
|
|
|
1.7 Clusters, Comorbidity and Context in Classification of Phobic Disorders |
|
|
47 | (3) |
|
|
|
1.8 Comorbidity in Social Phobia: Nosological Implications |
|
|
50 | (2) |
|
Constantin R. Soldatos and Thomas J. Paparrigopoulos |
|
|
|
1.9 Giving Credit to "Neglected" or "Minor" Disorders |
|
|
52 | (3) |
|
Charles Pull and Caroline Pull |
|
|
|
1.10 A Cognitive Approach to Phobias |
|
|
55 | (4) |
|
Jean-Pierre Lépine and Catherine Musa |
|
|
|
1.11 Diagnosis and Classification of Phobias and Other Anxiety Disorders: Quite Different Categories or Just One Dimension? |
|
|
59 | (2) |
|
|
CHAPTER 2 EPIDEMIOLOGY OF PHOBIAS |
|
61 | (56) |
|
Epidemiology of Phobias: A Review |
|
|
61 | (20) |
|
|
|
|
|
2.1 Risk-Factor and Genetic Epidemiology of Phobic Disorders: A Promising Approach |
|
|
81 | (4) |
|
|
|
2.2 Defining a Case for Psychiatric Epidemiology: Threshold, Non-Criterion Symptoms, and Category versus Spectrum |
|
|
85 | (4) |
|
Jack D. Maser and Jonathan M. Meyer |
|
|
|
2.3 Phobias: A Difficult Challenge for Epidemiology |
|
|
89 | (2) |
|
|
|
2.4 Phobias: Handy or Handicapping Conditions |
|
|
91 | (3) |
|
|
|
2.5 Phobic Disorders: Can We Integrate Empirical Findings with Clinical Theories? |
|
|
94 | (4) |
|
Marco Battaglia and Anna Ogliari |
|
|
|
2.6 Social Phobia and Bipolar Disorder: The Significance of a Counterintuitive and Neglected Comorbidity |
|
|
98 | (5) |
|
Hagop S. Akiskal and Giulio Perugi |
|
|
|
2.7 Comorbidity between Phobias and Mood Disorders: Diagnostic and Treatment Implications |
|
|
103 | (2) |
|
|
|
2.8 Epidemiology of Phobias: Old Terminology, New Relevance |
|
|
105 | (3) |
|
|
|
2.9 Phobias: Reflections on Definitions |
|
|
108 | (2) |
|
Elie G. Karam and Nay G. Khatcherian |
|
|
|
2.10 Phobias: Facts or Fiction? |
|
|
110 | (3) |
|
Rudy Bowen and Murray B. Stein |
|
|
|
2.11 Epidemiology of Phobias: The Pathway to Early Intervention in Anxiety Disorders |
|
|
113 | (4) |
|
Michael Van Ameringen, Beth Pipe and Catherine Mancini |
|
|
CHAPTER 3 PHARMACOTHERAPY OF PHOBIAS |
|
117 | (62) |
|
Pharmacotherapy of Phobias: A Review |
|
|
117 | (26) |
|
Dan J. Stein, Bavanisha Vythilingum and Soraya Seedat |
|
|
|
|
|
3.1 Placing the Pharmacotherapy of Phobic Disorders in a New Neuroscience Context |
|
|
143 | (3) |
|
|
|
3.2 Psychobiology and Pharmacotherapy of Phobias |
|
|
146 | (2) |
|
|
|
3.3 The Neuropsychology of Defence: Implications for Syndromes and Pharmacotherapy |
|
|
148 | (4) |
|
|
|
3.4 Social Phobia: Not Neglected, Just Misunderstood |
|
|
152 | (2) |
|
|
|
3.5 Research in Pharmacotherapy of Social Anxiety Disorder |
|
|
154 | (2) |
|
Siegfried Kasper and Dietmar Winkler |
|
|
|
3.6 Pharmacotherapy for Phobic Disorders: Where Do We Go from Here? |
|
|
156 | (2) |
|
|
|
3.7 Progress in Pharmacotherapy for Social Anxiety Disorder and Agoraphobia |
|
|
158 | (2) |
|
|
|
3.8 Psychopharmacology Treatment of Phobias and Avoidance Reactions |
|
|
160 | (3) |
|
|
|
3.9 Crowning Achievement: The Rise of Anti-phobic Pharmacotherapy |
|
|
163 | (2) |
|
|
|
3.10 Comorbidity and Phobias: Diagnostic and Therapeutic Challenges |
|
|
165 | (2) |
|
|
|
3.11 Comments on the Pharmacotherapy of Agoraphobia |
|
|
167 | (3) |
|
|
|
3.12 Pharmacotherapy of Phobias: A Long-Term Endeavour |
|
|
170 | (2) |
|
|
|
3.13 Behavioural Toxicity of Pharmacotherapeutic Agents Used in Social Phobia |
|
|
172 | (3) |
|
Ian Hindmarch and Leanne Trick |
|
|
|
3.14 Medication Treatment of Phobias: Theories Hide Effectiveness |
|
|
175 | (4) |
|
|
CHAPTER 4 PSYCHOTHERAPEUTIC INTERVENTIONS FOR PHOBIAS |
|
179 | (66) |
|
Psychotherapeutic Interventions for Phobias: A Review |
|
|
179 | (32) |
|
David H. Barlow, David A. Moscovitch and Jamie A. Micco |
|
|
|
|
|
4.1 Phobias: A Suitable Case for Treatment |
|
|
211 | (4) |
|
|
|
4.2 Cognitive-Behavioural Interventions for Phobias: What Works for Whom and When |
|
|
215 | (2) |
|
Richard G. Heimberg and James P. Hambrick |
|
|
|
4.3 Practical Comments on Exposure Therapy |
|
|
217 | (3) |
|
|
|
4.4 The Treatment of Phobic Disorders: Is Exposure Still the Treatment of Choice? |
|
|
220 | (3) |
|
|
|
4.5 "Behavioural Experimentation" and the Treatment of Phobias |
|
|
223 | (3) |
|
Yiannis G. Papakostas, Vasilios G. Masdrakis and George N. Christodoulou |
|
|
|
4.6 Evaluating the Durability of Cognitive-Behavioural Therapy |
|
|
226 | (2) |
|
Eberhard H. Uhlenhuth, Deepa Nadiga and Paula Hensley |
|
|
|
4.7 Some Comments on Psychological Treatment of Phobias |
|
|
228 | (4) |
|
|
|
4.8 Pushing the Envelope on Treatments for Phobia |
|
|
232 | (3) |
|
|
|
4.9 Treatment of Phobic Disorders from a Public Health Perspective |
|
|
235 | (2) |
|
|
|
4.10 Psychotherapeutic Interventions for Phobia: A Psychoanalytic-Attachment Perspective |
|
|
237 | (5) |
|
|
|
4.11 Psychotherapy in the Treatment of Phobias: A Perspective from Latin America |
|
|
242 | (3) |
|
|
CHAPTER 5 PHOBIAS IN CHILDREN AND ADOLESCENTS |
|
245 | (58) |
|
Phobias in Children and Adolescents: A Review |
|
|
245 | (35) |
|
Thomas H. Ollendick, Neville J. King and Peter Muris |
|
|
|
|
|
5.1 Childhood Phobias: More Questions than Answers |
|
|
280 | (3) |
|
|
|
5.2 Fear, Anxieties and Treatment Efficacy in Children and Adolescents |
|
|
283 | (2) |
|
|
|
5.3 Where Are All the Fearful Children? |
|
|
285 | (3) |
|
Gabrielle A. Carlson and Deborah M. Weisbrot |
|
|
|
5.4 Etiology and Treatment of Childhood Phobias |
|
|
288 | (2) |
|
Deborah C. Beidel and Autumn Paulson |
|
|
|
5.5 From Development Fears to Phobias |
|
|
290 | (2) |
|
|
|
5.6 Assessment and Treatment of Phobic Disorders in Youth |
|
|
292 | (3) |
|
|
|
5.7 Phobias: From Little Hans to a Bigger Picture |
|
|
295 | (2) |
|
|
|
5.8 Phobias in Childhood and Adolescence: Implications for Public Policy |
|
|
297 | (2) |
|
|
|
5.9 Phobias in Children and Adolescents: Data from Brazil |
|
|
299 | (2) |
|
Heloisa H.A. Brasil and Isabel AS. Bordin |
|
|
|
5.10 Phobias: A View from the South Seas |
|
|
301 | (2) |
|
|
CHAPTER 6 SOCIAL AND ECONOMIC BURDEN OF PHOBIAS |
|
303 | (52) |
|
Social and Economic Burden of Phobias: A Review |
|
|
303 | (26) |
|
Koen Demyttenaere, Ronny Bruffaerts and Andy De Witte |
|
|
|
|
|
6.1 Burden of Phobias: Focus on Health-Related Quality of Life |
|
|
329 | (3) |
|
Mark H. Rapaport, Katia K. Delrahim and Rachel E. Maddux |
|
|
|
6.2 Reducing the Burden of Phobias: Patient Factors, System Issues |
|
|
332 | (3) |
|
Naomi M. Simon and Julia Oppenheimer |
|
|
|
6.3 Health-Related Quality of Life: Disease-Specific and Generic Dimensions in Social Phobia |
|
|
335 | (2) |
|
|
|
6.4 What's So Different about Anxiety Disorders (Such as Phobias)? |
|
|
337 | (2) |
|
Paul E. Greenberg, Howard G. Birnbaum and Tamar Sisitsky |
|
|
|
6.5 Why Take Social Phobia Seriously? |
|
|
339 | (3) |
|
|
|
6.6 Phobias in Primary Care and in Young Children |
|
|
342 | (2) |
|
|
|
6.7 Treatments Are Needed to Reduce the Burden of Phobic Illness |
|
|
344 | (4) |
|
Peter P. Roy-Byrne and Wayne Katon |
|
|
|
6.8 Early Diagnosis Can Reduce the Social and Economic Burden of Phobias |
|
|
348 | (2) |
|
|
|
6.9 The High Cost of Underrecognition of Phobic Disorders |
|
|
350 | (2) |
|
|
|
6.10 Unanswered Questions on Phobias: What Can We Do to Meet the Need? |
|
|
352 | (3) |
|
|
Index |
|
355 | |